SUMMIT THERAPEUTICS INC (SMMT) Earnings History & Surprises

NASDAQ:SMMT • US86627T1088

16.08 USD
-0.25 (-1.53%)
At close: Mar 11, 2026
16.15 USD
+0.07 (+0.44%)
After Hours: 3/11/2026, 8:25:30 PM

Past quarterly earnings results for SUMMIT THERAPEUTICS INC (SMMT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate-$0.14
Revenue Estimate90.148K

Last Reported

Most Recent
Release DateJan 29, 2026
PeriodQ4 / 2025
EPS Reported-$0.29
EPS Surprise -341.96%
Revenue Surprise -100.00%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q4 2025 -0.29 -0.07 -341.96% -262.50% 92.727M -100.00% -
Q3 2025 -0.31 -0.13 -130.56% -287.50% - -
Q2 2025 -0.12 -0.10 -24.49% -33.33% - -
Q1 2025 -0.09 -0.09 3.04% -50.00% - -
Q4 2024 -0.08 -0.08 3.77% -100.00% - -100.00%
Q3 2024 -0.08 -0.07 -17.64% -166.67% - -100.00%
Q2 2024 -0.09 -0.06 -42.31% -350.00% - -
Q1 2024 -0.06 -0.06 1.96% - - -
Q4 2023 -0.04 - 42.86% 200K - -
Q3 2023 -0.03 - 78.57% 270K - 22.73%
Q2 2023 -0.02 - - - -100.00%
Q1 2023 -0.06 - - - -100.00%
Q4 2022 -0.07 - - - -100.00%
Q3 2022 -0.14 - 86.00% 220K - -83.21%
Q2 2022 - - 240K - 300.00%
Q1 2022 - - 250K - 31.58%
Q4 2021 - - 250K - 31.58%
Q3 2021 -1.00 -0.30 -238.07% 19.35% 1.31M - 627.78%
Q2 2021 0.00 - 99.77% 60K 4.518M -98.67% -64.71%
Q1 2021 -1.05 0.00 -39,799.68% -950.00% 190K 4.495M -95.77% -40.63%
Q4 2020 -0.90 0.00 -40,006.95% - 190K 3.913M -95.14% -
Q3 2020 -1.24 -0.01 -10,852.13% - 180K 4.041M -95.55% -
Q2 2020 -1.15 -0.02 -5,537.25% - 170K 4.59M -96.30% -
Q1 2020 -0.10 -0.02 -390.20% - 320K 5.171M -93.81% -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

SMMT EPS Q2Q GrowthSMMT EPS Q2Q GrowthEPS Q2Q Growth Q1/21 Q3/21 Q3/23 Q1/24 Q3/24 Q1/25 Q3/25 Q1/26 Q3/26 Q1/27 Q3/27 0 -200 -400 -600 -800

Revenue Historical Q2Q growth and Acceleration

SMMT Revenue Q2Q GrowthSMMT Revenue Q2Q GrowthRevenue Q2Q Growth Q1/21 Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q3/24 Q4/24 0 200 400 600

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
2
Average EPS beat (4)
-8.83%
Max EPS beat (4)
3.77%
Min EPS beat (4)
-24.49%

Revenue beat statistics

Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A

Analysis

In the last 4 quarters, SMMT has beaten EPS estimates in 2 out of 4 releases
In the last 4 quarters, SMMT reported -8.8% below the EPS estimates on average.
→ Find peers who consistently beat earnings by at least 10% in the last 4 quarters

SUMMIT THERAPEUTICS INC / SMMT Earnings FAQ

Can you provide the last earnings date for SUMMIT THERAPEUTICS INC?

SUMMIT THERAPEUTICS INC (SMMT) last reported earnings on 1/29/2026.


Can you provide information on whether SUMMIT THERAPEUTICS INC beat earnings estimates in the last quarter?

SUMMIT THERAPEUTICS INC (SMMT) missed EPS estimates and missed revenue estimates in the most recent quarter.


Can you provide information on how often SUMMIT THERAPEUTICS INC beats earnings estimates?

In the last 4 quarters, SUMMIT THERAPEUTICS INC (SMMT) has beaten EPS estimates in 2 out of 4 releases.